-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Downgrades Centessa Pharmaceuticals to Hold

Benzinga·03/31/2026 12:28:27
Listen to the news
Needham analyst Ami Fadia downgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Buy to Hold.